Analyst Ratings for Intra-Cellular Therapies (ITCI)

ITCI Rating Summary

ITCI Price Target Summary

* Over Last 12-Mos
  |   Expand Research on ITCI
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $68.27 (+17.9%) * Over Last 12-Mos
Rating Score: 8.8 / 10   Percentile Rank: 87%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
6/14/2022 UBS Ashwani Verma New Coverage Buy
(N/A)
75.00
(N/A)
53.02
(57.90)
9.2% Details
4/22/2022 Piper Sandler N/A New Coverage Neutral
(N/A)
59.00
(N/A)
55.75
(57.90)
3.86% Details
Like ITCI Ratings? Also take a look at NBIX, BIIB, BHVN, RPRX

ITCI Ratings News